Andy Martin
Advertisement
Articles by Andy Martin
The ICH hopes to avoid detrimental impacts of variability such as delays in medicine availability and the launch of new products, and different approaches to compliance inspections.
Advertisement
Latest Updated Articles
- Industry consults on new regulations
Published: January 1st 2007 | Updated:
- New regulation of children's medicines
Published: March 1st 2007 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
3
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
4
How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems
5
